Acanthas Pharma
Boston, United States· Est.
Acanthus Pharma delivers bespoke CDMO services that accelerate small‑molecule and gene‑delivery drug development for biotech and pharma clients.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Acanthus Pharma delivers bespoke CDMO services that accelerate small‑molecule and gene‑delivery drug development for biotech and pharma clients.
Small MoleculeGene Therapy
Technology Platform
Custom synthetic chemistry and process development combined with GMP manufacturing and lipid‑based excipient technologies for gene‑delivery therapeutics.
Opportunities
Expansion of lipid‑excipient platforms for RNA therapeutics and scaling GMP capacity to serve increasing demand for early‑stage clinical material.
Risk Factors
Intense competition from larger CDMOs and reliance on a limited client base could affect growth if market dynamics shift.
Competitive Landscape
Competes with global CDMOs like Lonza, Catalent, and Patheon; differentiates through boutique customization, deep chemistry expertise, and focus on gene‑delivery excipients.